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SUMMARY 
Background: The impact of unilateral extended autologous latissimus dorsi (EALD) 
flap harvest and axillary surgery on shoulder function has been well described, but the 
impact of bilateral EALD flap harvest not clearly defined.  Nor is it clear whether 
reconstructions should be synchronous, or staged.   
Methods: In this prospective observational study, patients undergoing bilateral 
EALD breast reconstruction (February 2003 - December 2009) completed the 
disability, arm, shoulder and hand (DASH) questionnaire pre-operatively, and at five 
post-operative time-points. Intensive shoulder physiotherapy was offered to those 
whose DASH score was >30 at 6 weeks, or >20 at 12 weeks post-operatively. 
Results: Sixty patients underwent bilateral EALD flap breast reconstruction (51 
synchronous, 9 metachronous). Patients with pre-existing shoulder pathology (n=1) 
and those who failed to return any post-operative DASH questionnaire (n=10) were 
excluded from initial DASH analysis. However, these eleven patients were included 
in a separate analysis as an intention to treat analysis. A statistical analysis was 
performed using non-parametric, Friedman test and multiple comparison model. 
Forty-nine patients’ DASH scores were analysed. DASH score initially increased 
after surgery then returned to functionally normal within 3-6 months (median DASH: 
pre-operative=1 vs. 6 weeks post-operative=26, P=<0.001; vs. 3 months=19, 
P=<0.001; vs 6 months=13, P=<0.001; thereafter the scores remained less than 12 
P=<0.001). Median DASH score after synchronous reconstruction was not higher 
than after metachronous reconstructions, although the metachronous sample size was 
small. 
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Conclusion: With appropriate patient selection and intensive physiotherapy bilateral 
EALD breast reconstruction does not appear to cause significant longterm impairment 
of shoulder function, and patients can now be counselled about the likely timecourse 
of shoulder recovery. There seems no reason to stage bilateral reconstruction in order 
to reduce shoulder morbidity. 
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INTRODUCTION 
The latissimus dorsi flap is a reliable, versatile and frequently used method in 
reconstructive breast surgery.1-3 In 1998, Delay demonstrated that the extended 
latissimus dorsi flap is able to offer adequate volume for breast reconstruction and 
minimise the need for an additional prosthesis.2,4 Accordingly, the extended 
autologous latissimus dorsi (EALD) flap accounted for 49% of all breast 
reconstructions in the Canniesburn Plastic Surgery Unit (2010-2011).  The impact 
upon upper limb function after unilateral reconstruction was previously studied in 
detail, using the Disabilities, Arm, Shoulder and Hand (DASH) questionnaire – the 
timecourse of recovery and longterm functional outcomes were favourable, with no 
deleterious effect of donor site quilting found.3 
Approximately 10% of all EALD breast reconstructions in the Canniesburn 
Plastic Surgery Unit are bilateral, and the frequency is increasing due to a pro-active 
risk stratification and prophylactic mastectomy.5,6 Reconstructions are performed 
either in one procedure (synchronous) for bilateral disease, or at different time-points 
(metachronous) for metachronous contralateral disease or risk reduction. The impact 
upon shoulder and upper limb function of these bilateral EALD procedures is not 
known. This study therefore established the timecourse of functional recovery in such 
patients, using the DASH questionnaire.  
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PATIENTS AND METHODS 
This was a prospective observational study with blinded data interpretation by 
an independent statistician. All patients undergoing bilateral EALD flap breast 
reconstruction within the Canniesburn Plastic Surgery Unit between February 2003 
and December 2009 were recruited (n=60, 51 synchronous & 9 metachronous), and 
their clinical and demographic data analysed (Table 1).  
Patients were appropriately counselled and had selected their reconstructive 
technique prior to recruitment. This study did not impact upon patient care. 
Operative technique 
Cases comprised a mixture of immediate (mainly skin-sparing mastectomy) 
and delayed reconstructions.  Some cases involved delayed reconstruction of one 
breast and immediate reconstruction of the other.  A previously described surgical 
technique3 was used, similar to that described by Delay.2,4 Fat was not harvested from 
the lower lumbar area because previous audit had demonstrated excessive fat necrosis 
(unpublished data).  
Bilateral synchronous EALD breast reconstructions undertaken by a single 
operator were performed one side at a time, with insetting finalized bilaterally after 
being returned to the supine position. When dual operators were present, both breast 
pockets were created with the patient supine, before turning prone to raise both flaps 
and pass them into the breast pockets.  The patient was turned supine for final 
insetting.  Metachronous reconstructions were performed as was previously described 
for unilateral reconstructions.3 
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In all reconstructions donor site closure was obtained over vacuum suction 
drains (ExudrainTM, Astratec, Sweden) using deep (3/0 VicrylTM, Ethicon, U.K.) 
followed by subcuticular absorbable sutures (VicrylTM/MonocrylTM Ethicon, U.K.). 
The practice of donor site quilting (2/0 polydioxanone, PDSIITM, Ethicon, UK) 
depended upon surgeon’s preference (28/60 of all cases; 22/49 of cases followed with 
DASH questionnaire). 
Post-operative Care 
An active shoulder exercise programme was initiated on the first post-
operative day.3 Prior to discharge (after drain removal when <50ml/24 h, or post-
operative day 7-10), patients were instructed on a home exercise programme, and 
given a written handout to follow.  They were advised to continue the illustrated 
exercises until post-operative day 14, then to gradually increase range of movement. 
Physiotherapy follow-up was not routinely provided. Patients who showed slow 
recovery at 6 weeks (DASH score >30) and 3 months (DASH score >20) were 
contacted and offered intensive outpatient physiotherapy. All patients attended nurse 
led dressing and breast care clinics as appropriate, in addition to surgical reviews.  
Primary outcome measure – DASH 
Patients were invited to complete the DASH questionnaire pre-operatively (on 
admission prior to surgery) and at the following five post-operative time-points: 6 
weeks, 3, 6, 12 months and at a subsequent final timepoint (12-36 months). Response 
rates were variable at different time-points (Table 2), and lowest at the 6 month 
timepoint (22 of 60 patients). 
Secondary outcome measures 
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In keeping with previous work3, relevant demographic data (age, chest 
circumference, cup size), co-morbidities, surgical treatment (timing of mastectomy 
and axillary dissection relative to reconstruction, adjuvant chemotherapy, 
radiotherapy, or hormonal management), presence of pre-existing shoulder 
conditions, intra-operative details (operative time, division of latissimus dorsi tendon 
or thoracodorsal nerve) and length of hospital stay were prospectively recorded. Post-
operative complications including wound dehiscence, formation of persistent donor 
site seroma (defined as serous collection requiring more than two aspirations), or 
those indicating re-operation were also recorded.  
Statistical analysis 
DASH scores were analysed from returned questionnaires, pre-operative and 
five post-operative time-points; and at each analysis p < 0.01 indicated a statistically 
significant difference between the timepoints. Clinical data were extracted from 
prospective records by a blinded assessor. Statistical analysis of the anonymised 
dataset was undertaken by an external, blinded, senior statistician. The Friedman-test 
was used for the DASH analysis of global cohort. Mann-Whitney Test was used for 
analysis of the metachronous cohort, due to small sample size. 
 
RESULTS 
Description of cohort  
Demographic and oncological data are summarised in Table 1. Patients were 
aged 25-69 years old (median 47). Forty-two patients had undergone axillary 
dissection, 34 had adjuvant radiotherapy and 44 received cytotoxic chemotherapy.  
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Metachronous bilateral reconstructions (BMEBR, N=9) were performed a 
median of 18 months apart. Synchronous bilateral reconstructions (BSEBR, N=51) 
were for immediate reconstruction of bilateral mastectomy (N=37), for delayed 
reconstruction after previous bilateral mastectomy (N=9), or for synchronous 
reconstruction after previous unilateral mastectomy (delayed side) and subsequent 
contralateral mastectomy (immediate side) (N=5).  
 All patients returned the pre-operative DASH questionnaire, returns at later 
timepoints were:  49/60 at 6 weeks (82%), 45/60 at 3 months (75%), 22/60 at 6 
months (36%), 47/60 at 12 months (78%) and 48/60 at the final timepoint (80%).  
Eleven patients did not return any postoperative DASH questionnaire, 
therefore we analysed data on patients who returned questionnaire at various time-
points and separately on all sixty patients on an intention to treat basis.  
Surgical outcome data 
Median operative duration for bilateral EALD breast reconstruction was 7 
hours (range 4 to 11 hours), and inpatient stay was 8 days (range 4 -10 days). Three 
patients (5%) required early reoperation for breast wound dehiscence (N=2 treated by 
split-thickness skin grafting, N=1 by direct closure), and two donor site infections 
were managed conservatively. Seven patients developed persistent donor site seroma 
(sufficient to indicate aspiration – 6 had no quilting and one quilting primarily), six 
were managed with aspiration and one required excision of seroma cavity and quilting 
of skin flaps. Nine received lipofilling to enhance breast contour (N=8) or for fat 
necrosis (N=1). 
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No flaps were lost, and no venous congestion was noted.  No patient 
developed thromboembolic disease, fluid overload, significant basal atelectasis or 
respiratory infection/distress, ileus or delayed gut function, or necrotising infection. 
Timecourse of change in DASH score after bilateral EALD breast reconstruction 
DASH score after all bilateral EALD breast reconstruction patients at all 
timepoints is illustrated in Table 2 and Figure 1 & 2.  
Statistical analysis was restricted to the datasets obtained from patients who 
returned post-operative DASH questionnaires (N=49), median DASH scores at 6 
weeks and 3 months after surgery were significantly elevated from the pre-operative 
score (minimal clinically significant change = 12.7 points; median increase from pre-
operative DASH after 6 weeks=25, after 3 months=18; both P=<0.001). The scores 
then improved (median DASH score, 6 months= 13, p=<0.001; 12 months=12, 
p=<0.001 and final timepoint=10, p=<0.001). Final functional outcome was 
‘functionally normal’, since the median DASH score remained <14.26 
Intention to treat analysis (including the eleven patients who returned a pre-
operative DASH questionnaire but no post-operative questionnaire) gave a similar 
pattern of results – scores were statistically significantly elevated at only 6 weeks and 
3 months after surgery (median DASH score preoperative=1; 6 weeks=25, 3 
months=20, both p=<0.0001). The final outcome after 6 months remained 
‘functionally normal’ <14 (Table 3).  
DASH scores at 6 weeks and 3 months after EALD flap breast reconstruction 
correlate with long-term outcome 
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Twenty of forty-nine patients (40%) returning scores at 6 weeks had DASH score 
>30, and 17 of 45 (37%) returning scores at 3 months had DASH >20. This group was 
identified as at risk of developing poor outcome and offered additional physiotherapy. 
Synchronous vs. metachronous bilateral EALD reconstruction 
Comparison of the DASH scores obtained from patients that underwent synchronous 
bilateral EALD breast reconstruction against those from patients that underwent 
metachronous bilateral EALD breast reconstruction (Figure 3) revealed that scores 
were higher in the metachronous group at all time-points studies (Table 4).  That 
difference was not clinically (ie. >12.7 points difference) or statistically significant at 
the 5% level (most likely due to small sample size in the metachronous group). This 
observation remained similar within the intention to treat analysis. Recovery from 
synchronous bilateral EALD breast reconstruction is no worse than that occurring 
after each episode of metachronous reconstruction, and there is a trend towards better 
functional recovery after synchronous bilateral breast reconstruction.  
 
DISCUSSION 
Breast cancer occurs bilaterally in 2–12% of women.7,8 The published risk of 
synchronous contralateral breast cancer varies from 1-3%, and of metachronous 
contralateral disease is 1-12% of patients. The risk of developing any contralateral 
breast cancer is 1-5% per annum.9-13  Furthermore, the increased availability of 
genetic and other breast cancer risk assessments tools has made risk reducing 
interventions (including prophylactic mastectomy14) more common, also increasing 
the need for bilateral breast reconstruction.  
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Options for breast reconstruction after mastectomy include implant-based 
techniques, and those solely employing autologous tissue. Implant based 
reconstruction is an attractive, easy and convenient option, but the results may worsen 
over time, especially after radiotherapy.15 In contrast, autologous reconstructions 
place greater demand on the patient in the short term, but give more natural 
consistency with the native breast16, and a reduced need for subsequent revision. 
Paolini et al17 presented a lower complication and reoperation rate than that published 
after bilateral implant with latissimus dorsi flap reconstruction (50%). 
The most commonly used techniques for autologous breast reconstruction are 
pedicled or free abdominal flaps, and latissimus dorsi flaps that may either be 
extended, or combined with a prosthesis. The free abdominal flap in its various forms 
has become a routine and highly effective technique for breast reconstruction, 18,19 but 
it has certain disadvantages that potentially include longer anaesthesia, protracted 
postoperative convalescence, abdominal pain, respiratory splinting, possible reduction 
of abdominal wall strength20, and partial flap failure21.  Complete flap loss occurs in a 
small percentage of every large reported series.  Potentially life-threatening 
complications (e.g. pulmonary embolism21, abdominal necrotising fasciitis22) are rare, 
but reported with greater frequency than for other reconstructive techniques. 
Additionally, other patient factors such as diabetes mellitus, tobacco smoking, 
chest wall radiotherapy, abdominal scars, and obesity can affect outcome23,24,. 
However, the autologous latissimus dorsi is able to offer satisfactory outcomes even 
for these high-risk patients and the extended flap can provide sufficient volume for 
implant-free breast reconstruction.2,3,23,24 
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Published literature suggests that, on balance, there is no significant longterm 
impact upon shoulder function from latissimus dorsi transfer, when assessed by a 
range of outcome measures3,25,26, although all studies document temporary shoulder 
dysfunction, and infrequent patients with more noticeable longterm deficits.2,27  The 
physical assessment methods used could be challenged 28,29, but more robust studies 
have suggested the presence of some loss of power and endurance.30  Pedicled 
transfer was also associated with mildly reduced function in certain activities (e.g. 
ladder climbing, painting above shoulder level and pushing up from a chair), although 
free flap transfer was not. Spear and Hess31 concluded that patients may experience 
deficits in adduction and extension during overhead or prolonged function, but no 
decrease in the range of shoulder motion. The relative impact of latissimus dorsi 
transfer, as opposed to mastectomy or axillary treatment in breast reconstruction has 
not been clearly defined, and the majority of patients do not describe any significant 
impact upon daily function.3,27 
The DASH questionnaire for shoulder function assessment has been 
recognized as a simple, reliable and an acceptable functional assessment tool.3,32  
Based on a 30 item self-administered questionnaire, it measures the patient reported 
global functional deficit rather than focusing only on isolated movements. The score 
is calculated using DASH formula, where a score of 0 correlates to no functional 
deficit and 100 correlates maximum functional impairment. Evidence suggests that a 
DASH score of 20-30 indicates a level of function enabling to work, whereas that of 
50-60 indicates inability to work and impairment of activities of daily living. To 
differentiate a true change in clinical status from potential measurement error requires 
a minimum change of 12.7 points (MDC95).3,32  
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After unilateral EALD breast reconstruction Button et al3 demonstrated a 
statistically and clinically significantly increase in DASH score at the initial post-
operative review and up to 3 months after surgery.  Shoulder function then returned to 
normal, and remained so 3 years after surgery. This study demonstrates the same 
pattern of recovery, and lack of longterm deficit, after bilateral EALD breast 
reconstruction. Recovery from synchronous bilateral reconstruction was no worse 
than after unilateral reconstruction, or after each episode of bilateral staged 
reconstruction. 
Koh and Morrison33 report a retrospective assessment of bilateral non-
extended ALD reconstructions, applying the DASH questionnaire at one post-
operative timepoint by telephone, in contrast to established DASH methodology.  
Only four bilateral cases were reported, with no comment as to whether 
reconstructions were synchronous or metachronous. One case had a DASH score of 
31.  Although it was concluded that bilateral LD flap harvest can cause significant 
deficits in sporting ability and warned against use, there are obvious methodological 
weaknesses to the study including lack of pre-operative screening for shoulder 
dysfunction. Paolini et al17 reported one-off DASH score >12 months after delayed 
metachronous implant with latissimus dorsi flap reconstruction, and showed 
infrequent functional deficit to relate to revisionary surgery due to complications.  
The results of this study show that the overwhelming majority of patients do not 
develop significant shoulder dysfunction, and that the complication profile and 
recovery time is favourable in comparison to that of bilateral DIEAP flap 
reconstruction.   
Yang et al34 conducted a prospective study of physical and functional 
disability and quality of life after immediate latissimus dorsi flap reconstruction, by 
 15 
using manual muscle test, range of motion and DASH. The DASH analysis was 
performed pre-operative and three post-operative time-points (3 months, 6 months 
and 12 months). The authors reported significant increase in the functional disability 
at 3 months (Mean scores at 3 months, 18.0 +/- 8.89, p < 0.001) and reduced but 
persistently elevated at 12 months (Mean scores at 12 months 13.8 +/- 4.25, p < 
0.001). The authors concluded shoulder strength and range of motion returned to 
baseline but functional disability persisted at one year after reconstruction. They also 
reported confounding factor of high drop out rate of their cohort (91 recruited and 31 
analysed), small sample size and suggested a long-term follow-up.   
Use of the EALD flap also seems more pertinent than the DIEAP for the 
unilateral autologous reconstruction case in whom risk stratification indicates an 
increased possibility of subsequent contralateral mastectomy.  In these patients the 
same reconstruction could then be used for the metachronously for the contralateral 
breast, if required, optimizing reconstructive symmetry. 
We believe women should be appropriately counselled regarding options for 
breast reconstruction, and that the selection of technique should be individualised.  
Women should be screened to detect those with high sporting / occupational shoulder 
function requirements, or pre-existing shoulder pathology, and should complete a 
DASH questionnaire to further detect those at risk of shoulder dysfunction from 
EALD breast reconstruction. These groups should carefully consider whether the 
EALD flap is the right reconstruction for them. However the majority of women can 
be advised that they will develop mild-moderate shoulder symptoms for around 6-12 
weeks, and then return to essentially normal function. There is no objective reason to 
avoid the use of the EALD flap for bilateral reconstructions, and synchronous 
reconstruction offer the patient the least downtime.  As for unilateral reconstruction, it 
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seems pertinent to screen for a high DASH score at 6 weeks after surgery, and target 
those patients with more intensive physiotherapy with the aim of improving long-term 
function.  
Future studies should delineate the impact of EALD flap use in patients with 
challenging shoulder functional requirements (e.g. high-level gymnasts, golfers, 
swimmers, etc.). 
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Table 1: Demographic & cancer management summary data 
 BEBR Cohort 
N 60 
Age 47 years (range 25-69) 
BMI 26 (range 20-37) 
Smoker 16 of 60 
Chest circumference (median) 36 (range 32-42) 
Cup size (median) C (range A-E) 
Pre-operative DASH (median) 1; Interquartile range 7 
Immediate vs Delayed reconstruction 45 vs 15* 
Axillary dissection 41 of 60 
Axillary radiotherapy 34 of 60 
19 prior to reconstruction 
14 subsequent 
1 pre & post reconstruction 
Cytotoxic chemotherapy 44 of 60 
20 prior to reconstruction 
20 subsequent 
1 synchronous 
3 pre & post reconstruction 
**of 15 metachronous reconstructions, 6 unilateral mastectomy cases underwent delayed ipsilateral 
reconstruction plus delayed contralateral mastectomy and immediate reconstruction; 9 bilateral 
mastectomy cases underwent a unilateral delayed reconstruction followed by another unilateral 
reconstruction. BEBR – Bilateral EALD Breast Reconstruction. 
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Table 2: Descriptive statistical analysis of DASH scores of BEBR.  (BEBR - Bilateral 
EALD Breast Reconstruction) 
 
Timepoint N at Timepoint Median Range Interquartile 
Range 
 
 
Pre-Op           60        1 0 - 77            0 - 7 
6 weeks           49        26 3 - 82            3 - 44 
3 months           45        19 1 - 57            1 - 38 
6 months           22        13 0 - 49            0 - 21 
12 months           47        12 0 - 53            0 - 20 
12-36 months*           48        10 0 - 48            6 - 16 
*Final timepoint;  
 
 
 
 
 
 
 
 
 
 
 
 
 23 
Table 3: Descriptive analysis of DASH score in all BEBR with intention to treat 
analysis. The last DASH score of all patients were analysed at each timepoint. 
Timepoint N at Timepoint Median Range Interquartile Range 
 
 
Pre-Op           60        1 0 - 77            0 - 7 
6 weeks           60        25 0 - 82            19 - 39 
3 months           60        20 0 - 82            9 - 33 
6 months           60        13 0 - 82            0 - 21 
12 months           60        13 0 - 82            7 - 22 
12-36 months*           60        10 0 - 82            6 - 21 
*Final Timepoint, BEBR – Bilateral EALD Breast Reconstruction 
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Table 4: Descriptive analysis of DASH scores in BSEBR and BMEBR.  
 
Timepoint Group N at Timepoint Median Range Interquartile 
Range 
Pre-op M 
S 
9 
51 
0 
1 
0-22 
0-77 
0-5 
0-8 
6 weeks M 
S 
8 
41 
33 
25 
16-80 
3-82 
26-54 
21-42 
3 months M 
S 
8 
37 
29 
19 
9-50 
1-57 
18-44 
8-32 
6 months M 
S 
4 
18 
15 
13 
12-33 
0-49 
12-29 
8-21 
12 months M 
S 
8 
39 
21 
12 
1-45 
0-53 
11-38 
7-16 
12-36months* M 
S 
8 
40 
17 
9 
1-45 
0-48 
10-38 
6-15 
*Final timepoint; BSEBR - Bilateral Synchronous EALD Breast Reconstruction; 
BMEBR – Bilateral Metachronous EALD Breast Reconstruction 
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Figure 1: Timecourse of change in median DASH score after whole bilateral EALD 
breast reconstruction (BEBR) cohort. The median DASH scores (X-axis) and various 
timepoints (Y-axis). The median DASH scores were significantly elevated at 6 weeks 
and 3 months post-operatively p < 0.01, but remained less than to 14 (functionally 
normal).  
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Figure 2: The box and whisker plot shows the distribution of DASH scores over time, 
i.e. Pre-operative, and 5 postoperative time points. The box denotes median (central 
bar of the box), interquartile range (upper and lower end of the box) and range 
(minimum and maximum; vertical lines extending from the box - whiskers); * shows 
outliers in the data set. 
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Figure 3: Timecourse of change in DASH score after BSEBR vs BMEBR. (BSEBR - 
Bilateral Synchronous EALD Breast Reconstruction; BMEBR – Bilateral 
Metachronous EALD Breast Reconstruction; * Final timepoint) 
 
 
 
 
 
 
 
 
 
 
 
